ALFA Finder
18:57 IST
NSE
Earnings Call
Dr. Agarwals Health Care Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Dr. Agarwals Health Care Ltd
- Share price
- ₹553.60
- Market cap
- ₹17,555 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 101.2×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Employee Stock Options 8Merger & Restructuring 7Earnings Call 5Financial Results 4Share Pledge 3Other Announcement 3Management Change 3Board Meeting Date 3Annual General Meeting 3Acquisition 3Legal & Regulatory 1Credit Rating 1Capital Structure Change 1Capacity Expansion 1Business Update 1Board Meeting Outcome 1
Time
5 announcements with these filters
18:10 IST
BSE
Earnings Call
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%). H1 FY27 revenue ₹1,269 Cr (+28.7%), PAT ₹112 Cr (+50.1%). Strategy is aggressive facility expansion, with 65 FY27E additions.
14:13 IST
BSE
Earnings Call
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Dr. Agarwal’s reported strong Q1FY27 results with revenue of ₹614 Cr and EBITDA of ₹177 Cr. Strategy focuses on aggressive 'Greenfield' expansion and hub-and-spoke scalability across India and Africa.
13:44 IST
BSE
Earnings Call
Dr. Agarwals Health Care Earnings Call: Key Takeaways
Dr. Agarwal’s reported strong FY26 performance, crossing INR 2,000cr revenue milestone with significant network expansion and EBITDA margin improvement to 28.9%.
18:21 IST
BSE
Earnings Call
Dr. Agarwals Health Care Earnings Call: Key Takeaways
Dr. Agarwals reported 21% income growth in FY26, driven by aggressive network expansion (57 new facilities) and clinical excellence.